FR2433525A1 - Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant - Google Patents

Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant

Info

Publication number
FR2433525A1
FR2433525A1 FR7920698A FR7920698A FR2433525A1 FR 2433525 A1 FR2433525 A1 FR 2433525A1 FR 7920698 A FR7920698 A FR 7920698A FR 7920698 A FR7920698 A FR 7920698A FR 2433525 A1 FR2433525 A1 FR 2433525A1
Authority
FR
France
Prior art keywords
production process
imidazole derivatives
pharmaceutical composition
composition containing
novel imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7920698A
Other languages
English (en)
Other versions
FR2433525B1 (fr
Inventor
Peter Edward Cross
Roger Peter Dickinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of FR2433525A1 publication Critical patent/FR2433525A1/fr
Application granted granted Critical
Publication of FR2433525B1 publication Critical patent/FR2433525B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

L'invention a trait au domaine de la chimie pharmaceutique. Elle concerne certains nouveaux dérivés d'imidazole, notamment certaines 2-(imidazole-1-ylméthyl)pyridines et -quinoléines, ainsi que leur procédé de production. Les composés de l'invention sont capables d'inhiber sélectivement l'action enzymatique de la thromboxane synthétase sans inhiber notamment l'action enzymatique de la prostacycline synthétase ou de la cyclo-oxygénase. On peut donc les utiliser dans le traitement des troubles cardiaques ischémiques, de l'apoplexie, de la thrombose, de l'attaque ischémique transitoire, de la migraine et des complications vasculaires du diabète.
FR7920698A 1978-08-15 1979-08-14 Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant Granted FR2433525A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7833456 1978-08-15
GB7926146A GB2028317B (en) 1978-08-15 1979-07-26 2-(imidazol-1-ylmethyl)-pyridine and -quinoline thromboxane synthetase inhibitors

Publications (2)

Publication Number Publication Date
FR2433525A1 true FR2433525A1 (fr) 1980-03-14
FR2433525B1 FR2433525B1 (fr) 1981-12-11

Family

ID=26268547

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7920698A Granted FR2433525A1 (fr) 1978-08-15 1979-08-14 Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant

Country Status (8)

Country Link
US (1) US4230714A (fr)
AU (1) AU4989579A (fr)
BE (1) BE878230A (fr)
DE (1) DE2932967A1 (fr)
FR (1) FR2433525A1 (fr)
GB (1) GB2028317B (fr)
LU (1) LU81598A1 (fr)
NL (1) NL7906148A (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR71915B (fr) * 1979-11-27 1983-08-16 Pfizer
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
ZA825413B (en) * 1981-08-26 1983-06-29 Pfizer Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
DE3333314A1 (de) * 1983-09-15 1985-03-28 Hoechst Ag, 6230 Frankfurt Substituierte pyrido(1,2-c)imidazo(1,2-a)benzimidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
JPS61110266A (ja) * 1984-11-05 1986-05-28 Omron Tateisi Electronics Co カード発行方法
JP2581556B2 (ja) * 1986-05-06 1997-02-12 メレルダウファーマスーティカルズ インコーポレーテッド 新規なドパミンベ−タヒドロキシラ−ゼ抑制剤
EP0269030B1 (fr) * 1986-11-20 1994-05-04 Mitsubishi Kasei Corporation Composition inhibitrice de la formation lipide-peroxyde et composé utilisables dans cette composition
DE3811574A1 (de) * 1988-03-31 1989-10-19 Schering Ag N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
DE4131584A1 (de) * 1991-09-23 1993-03-25 Sandoz Ag Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika
CN1040107C (zh) * 1993-01-02 1998-10-07 山道士有限公司 咪唑基甲基吡啶
GB0009037D0 (en) * 2000-04-13 2000-05-31 Novartis Ag Organic compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH204740A (de) * 1935-07-23 1939-05-15 Chem Ind Basel Verfahren zur Darstellung eines in 2-Stellung substituierten Imidazoldihydrids-(4,5).
FR1479120A (fr) * 1965-05-10 1967-04-28 Ward Blenkinsop & Co Ltd Composés imidazoliques et leur préparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL135940C (fr) * 1965-05-10
US4058614A (en) * 1973-12-04 1977-11-15 Merck & Co., Inc. Substituted imidazole compounds and therapeutic compositions therewith
DE2418502C3 (de) * 1974-04-11 1980-04-24 Schering Ag, 1000 Berlin Und 4619 Bergkamen Dichlorbenzyl- [2-( a -imidazolylbutyl)-phenyl] -äther und -thioäther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH204740A (de) * 1935-07-23 1939-05-15 Chem Ind Basel Verfahren zur Darstellung eines in 2-Stellung substituierten Imidazoldihydrids-(4,5).
FR1479120A (fr) * 1965-05-10 1967-04-28 Ward Blenkinsop & Co Ltd Composés imidazoliques et leur préparation

Also Published As

Publication number Publication date
FR2433525B1 (fr) 1981-12-11
GB2028317B (en) 1982-11-10
DE2932967A1 (de) 1980-03-20
US4230714A (en) 1980-10-28
LU81598A1 (fr) 1981-03-24
GB2028317A (en) 1980-03-05
BE878230A (fr) 1980-02-13
NL7906148A (nl) 1980-02-19
AU4989579A (en) 1980-02-21

Similar Documents

Publication Publication Date Title
FR2433525A1 (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
FR2450832A1 (fr) Nouveaux 3-(1-imidazolylalkyl) indoles, leur procede de production et composition pharmaceutique les contenant
ES8101556A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
MA44851A (fr) Dérivés pyridinyltriazole substitués par des groupements amides et leurs utilisations
FR2436602A1 (fr) Composition pharmaceutique renfermant des composes retinoyliques et procede de production de ces composes
HUP0000323A2 (hu) N-Szubsztituált 2-ciano-pirrolidin-származékok, eljárás előállításukra, valamint a vegyületeket tartalmazó gyógyszerkészítmények
FR2407926A1 (fr) Derives de quinazoline, leur procede de production et composition pharmaceutique les contenant
ATE290386T1 (de) Verfahren zur herstellung von di-beta-d- glucopyranosylamin-verbindungen zur regulierung von entzündungsprozessen
FR2385506A1 (fr) Procede de traitement du bois par un agent de preservation du bois et bois traite par ledit agent de preservation du bois
RU94042907A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ ее получения
ATE273279T1 (de) 2,3,5-trisubstituierte pyridine als inhibitoren von cyclooxygenase-2
FR2422657A1 (fr) 2-(2-thenoylthio)-propionylglycine, procede pour sa preparation et compositions pharmaceutiques la contenant
FR2424908A1 (fr) Nouveaux analogues de prostacycline, leur procede de production et medicament les contenant
FR2354324A1 (fr) Nouveaux composes triazoliques, leur procede de preparation et leurs applications au traitement de plantes
TNSN98185A1 (fr) Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2393848A1 (fr) Procede pour preparer des d-a-amino-acides par voie enzymatique
RU94019981A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ их получения
FR2359203A1 (fr) Polysaccharides, leur procede de preparation et medicaments les contenant
MA21902A1 (fr) Procede pour la preparation de peptitides hemoregulateurs et des compositions pharmaceutiques les comtenant .
FR2394522A1 (fr) Nouveaux derives d'acides (s-phenenyl tris(carbonylimino))-5,5',5''tri-benzene-carboxyliques utiles notamment comme inhibiteurs du complement, et leur procede de preparation
FR2424024A1 (fr) Procede pour la preparation d'une lotion capillaire agissant contre la chute des cheveux ainsi que lotion capillaire obtenue par ce procede
FR2418789A1 (fr) Nouveaux sels de guanidine, procede permettant leur production et preparations microbicides les contenant
FR2364886A1 (fr) Polyamines alkylees, procede pour leur preparation et application de ces corps, notamment comme microbicides
FR2409986A1 (fr) Procede de production de moranoline et nouveau produit ainsi obtenu

Legal Events

Date Code Title Description
ST Notification of lapse